Wilmington Savings Fund Society’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
12,459
-194
-2% -$25.6K 0.04% 254
2026
Q1
$1.76M Buy
12,653
+100
+0.8% +$14K 0.04% 243
2025
Q4
$1.54M Buy
12,553
+18
+0.1% +$2.19K 0.04% 257
2025
Q3
$1.39M Sell
12,535
-5,656
-31% -$643K 0.03% 266
2025
Q2
$2.02M Sell
18,191
-660
-4% -$70.2K 0.04% 303
2025
Q1
$2.11M Sell
18,851
-1,082
-5% -$112K 0.04% 296
2024
Q4
$1.84M Buy
19,933
+1,273
+7% +$115K 0.03% 313
2024
Q3
$1.56M Buy
18,660
+13,729
+278% +$1.05M 0.03% 346
2024
Q2
$338K Sell
4,931
-1,000
-17% -$66.7K 0.01% 297
2024
Q1
$434K Buy
+5,931
New +$456K 0.02% 275
2023
Q3
$444K Sell
5,931
-890
-13% -$68.5K 0.02% 262
2023
Q2
$525K Buy
6,821
+1,870
+38% +$149K 0.02% 255
2023
Q1
$411K Sell
4,951
-1,000
-17% -$82.8K 0.02% 274
2022
Q4
$511K Hold
5,951
0.02% 250
2022
Q3
$367K Hold
5,951
0.02% 283
2022
Q2
$368K Sell
5,951
-228
-4% -$14.1K 0.02% 284
2022
Q1
$367K Sell
6,179
-293
-5% -$18.7K 0.01% 299
2021
Q4
$470K Sell
6,472
-2,275
-26% -$157K 0.02% 285
2021
Q3
$611K Buy
8,747
+1,996
+30% +$140K 0.02% 267
2021
Q2
$465K Buy
6,751
+265
+4% +$17.7K 0.02% 289
2021
Q1
$419K Sell
6,486
-117
-2% -$7.54K 0.02% 290
2020
Q4
$384K Sell
6,603
-1,625
-20% -$98.1K 0.02% 297
2020
Q3
$520K Sell
8,228
-807
-9% -$56K 0.02% 264
2020
Q2
$695K Hold
9,035
0.03% 241
2020
Q1
$675K Buy
9,035
+3,530
+64% +$244K 0.04% 225
2019
Q4
$357K Sell
5,505
-836
-13% -$54.4K 0.02% 281
2019
Q3
$402K Sell
6,341
-2,383
-27% -$156K 0.02% 265
2019
Q2
$589K Sell
8,724
-112,532
-93% -$7.4M 0.03% 235
2019
Q1
$7.88M Buy
121,256
+6,561
+6% +$436K 0.43% 83
2018
Q4
$7.17M Sell
114,695
-11,628
-9% -$813K 0.44% 80
2018
Q3
$9.75M Buy
126,323
+1,488
+1% +$112K 0.51% 65
2018
Q2
$8.84M Buy
124,835
+3,353
+3% +$237K 0.49% 69
2018
Q1
$9.16M Buy
121,482
+1,511
+1% +$120K 0.52% 61
2017
Q4
$8.59M Sell
119,971
-23,882
-17% -$1.81M 0.47% 67
2017
Q3
$11.7M Buy
143,853
+6,279
+5% +$480K 0.67% 48
2017
Q2
$9.74M Sell
137,574
-4,237
-3% -$282K 0.58% 52
2017
Q1
$9.63M Buy
141,811
+3,620
+3% +$255K 0.58% 50
2016
Q4
$9.89M Sell
138,191
-25,534
-16% -$1.9M 0.62% 48
2016
Q3
$13M Buy
163,725
+2,777
+2% +$226K 0.82% 36
2016
Q2
$13.4M Buy
160,948
+1,102
+0.7% +$97.8K 0.85% 34
2016
Q1
$14.7M Buy
159,846
+1,880
+1% +$170K 0.94% 29
2015
Q4
$16M Buy
157,966
+1,211
+0.8% +$126K 1% 28
2015
Q3
$15.4M Buy
156,755
+2,425
+2% +$269K 0.99% 26
2015
Q2
$18.1M Buy
154,330
+1,981
+1% +$216K 1.05% 24
2015
Q1
$14.9M Buy
152,349
+139,199
+1,059% +$14.1M 0.85% 31
2014
Q4
$1.24M Buy
13,150
+200
+2% +$20.7K 0.07% 199
2014
Q3
$1.38M Sell
12,950
-1,890
-13% -$185K 0.08% 202
2014
Q2
$1.23M Hold
14,840
0.07% 214
2014
Q1
$1.05M Hold
14,840
0.06% 226
2013
Q4
$1.11M Sell
14,840
-54
-0.4% -$3.76K 0.06% 220
2013
Q3
$936K Hold
14,894
0.06% 227
2013
Q2
$763K Buy
+14,894
New +$776K 0.05% 240

Other funds holding GILD

Wilmington Savings Fund Society's GILD Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $25.6K and leaving 12,459 shares worth $1.57M. The position accounts for 0.04% of the portfolio, ranked #254.

Wilmington Savings Fund Society first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.1M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wilmington Savings Fund Society held 12,459 shares of Gilead Sciences worth $1.57M as of Q2 2026.
  • Wilmington Savings Fund Society sold 194 Gilead Sciences shares in Q2 2026, an estimated $25.6K.
  • Gilead Sciences made up 0.04% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #254 holding.
  • Wilmington Savings Fund Society first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Wilmington Savings Fund Society's Gilead Sciences position peaked at $18.1M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.